PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Preliminary clinical assessment of glucaron, pharmacon in preventing recurrences of superficial bladder tumours
Article published in Urologia Polska 1983/36/3.

authors

Tadeusz Krzeski, Andrzej Borkowski
Klinika Urologiczna Instytutu Chirurgii Akademii Medycznej w Warszawie
Kierowniki: prof. dr hab. med. T. Krzeski

summary

Own experiences in prevention of recurrences after transurethral electrore-section of superficial bladder tumours with orał Glucaron, Pharmacon are repor­ted. The drug is an inhibitor of glucuronidase and is well absorbed from the di-gestive tract.
The observed group included 16 patients in whom the frequency of recurren­ces was reduoed during the treatment. No toxicity of the drug was observed.

references

  1. Boyland E., Wallace D. M., Avis P. R. D., Kinder C. H.: Attempted prophy-laxis of bladder cancer with 1?4 Glucosaocharolactone. Brit. J. Urol., 1964, 36, 563.
  2. Jacobi G. H.: Chemotherapy for urinary bladder cancer: developments, trends and future perspectives, w książce: Clinical bladder cancer. Plenum Press, 1982, New York.
  3. Panasiewicz K.: Zawodowy rak pęcherza moczowego. Pam. XI Zjazdu P. T. U., Łódź, 1968, 53.
  4. Documentation Pharmakon Ziirich: Glu­caron tablełs, Chugai Pharmaceutical Co, Ltd., 1979.